Registre des actions collectives

Aperçu de la demande d’action collective 500-06-000591-129

Impression de l'aperçu de la demande d'action collective

Étape de la demande :

Autorisation - Demande d’autorisation pour exercer l’action collective à la Cour supérieure

Palais de justice :

Montréal

Date de dépôt de la demande d'autorisation :

2012-01-20

No de dossier :

500-06-000591-129

Sujet :

Protection du consommateur; Protection du consommateur

Cette affaire concerne :

Nom des parties :

Guy Belair v. Bayer Inc., et al.

Description du groupe qui intente l'action :

All persons and entities in Canada (including their estates, executors, or personal representatives) that purchased, used, or acquired Avelox®, a fluroquinolone antibiotic, and their dependants and family members, or any other Class or Sub-Class to be determined by the Court (the “Class” or “Class Members”)All persons and entities in Canada (including their estates, executors, or personal representatives) that purchased, used, or acquired Avelox®, a fluroquinolone antibiotic, and their dependants and family members, or any other Class or Sub-Class to be determined by the Court (the “Class” or “Class Members”)All persons and entities in Canada (including their estates, executors, or personal representatives) that purchased, used, or acquired Avelox®, a fluroquinolone antibiotic, and their dependants and family members, or any other Class or Sub-Class to be determined by the Court (the “Class” or “Class Members”)All persons and entities in Canada (including their estates, executors, or personal representatives) that purchased, used, or acquired Avelox®, a fluroquinolone antibiotic, and their dependants and family members, or any other Class or Sub-Class to be determined by the Court (the “Class” or “Class Members”)All persons and entities in Canada (including their estates, executors, or personal representatives) that purchased, used, or acquired Avelox®, a fluroquinolone antibiotic, and their dependants and family members, or any other Class or Sub-Class to be determined by the Court (the “Class” or “Class Members”)

Documents et actes de procédure :

Document Date du document
Demande d’autorisation d’exercer une action collective 2012-01-20
Réponse 2012-04-19

Avocats de la partie demanderesse :

Nom Courriel Téléphone Adresse Nom du cabinet Site web
Chung, Daniel [email protected] (514)842-7776 10 Notre-Dame Est, Suite 200, Montreal, Québec, Canada , H2Y 1B7 Merchant Law Group www.merchantlaw.com

Avocats de la partie défenderesse :

Nom Courriel Téléphone Adresse Nom du cabinet
Rodrigue, Sylvie (514)847-4559 1, place Ville Marie, bureau 2500, Montréal, Québec, Canada , H3B 1R1 Norton Rose Canada S.E.N.C.R.L.

Étape de la demande

1 - Autorisation - Demande d’autorisation pour exercer l’action collective à la Cour supérieure

Palais de justice

Montréal

Date de dépôt de la demande d'autorisation

2012-01-20

No de dossier

500-06-000591-129

Sujet

Protection du consommateur; Protection du consommateur

Cette affaire concerne

Nom des parties

Guy Belair v. Bayer Inc., et al.

All persons and entities in Canada (including their estates, executors, or personal representatives) that purchased, used, or acquired Avelox®, a fluroquinolone antibiotic, and their dependants and family members, or any other Class or Sub-Class to be determined by the Court (the “Class” or “Class Members”)All persons and entities in Canada (including their estates, executors, or personal representatives) that purchased, used, or acquired Avelox®, a fluroquinolone antibiotic, and their dependants and family members, or any other Class or Sub-Class to be determined by the Court (the “Class” or “Class Members”)All persons and entities in Canada (including their estates, executors, or personal representatives) that purchased, used, or acquired Avelox®, a fluroquinolone antibiotic, and their dependants and family members, or any other Class or Sub-Class to be determined by the Court (the “Class” or “Class Members”)All persons and entities in Canada (including their estates, executors, or personal representatives) that purchased, used, or acquired Avelox®, a fluroquinolone antibiotic, and their dependants and family members, or any other Class or Sub-Class to be determined by the Court (the “Class” or “Class Members”)All persons and entities in Canada (including their estates, executors, or personal representatives) that purchased, used, or acquired Avelox®, a fluroquinolone antibiotic, and their dependants and family members, or any other Class or Sub-Class to be determined by the Court (the “Class” or “Class Members”)
Retour